CCR5 and HIV-1 infection: Very recently, Xu et al. reported successful allogeneic transplantation and long-term engraftment of HSCs with CCR5 ablation by a CRISPR/Cas9-based gene editing system in a patient with HIV-1 infection and acute lymphoblastic leukemia, which demonstrated safety but showed no therapeutic effect in terms of viral replication14.